Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.
2.

An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.

Wang Y, Wang J, Gao L, Stamm S, Andreadis A.

Gene. 2011 Oct 10;485(2):130-8. doi: 10.1016/j.gene.2011.06.020. Epub 2011 Jun 30.

3.
4.
5.

Regulation of alternative splicing of tau exon 10.

Qian W, Liu F.

Neurosci Bull. 2014 Apr;30(2):367-77. doi: 10.1007/s12264-013-1411-2. Epub 2014 Mar 14. Review.

6.

Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.

Gu J, Chen F, Iqbal K, Gong CX, Wang X, Liu F.

J Biol Chem. 2017 Jun 23;292(25):10600-10612. doi: 10.1074/jbc.M117.783498. Epub 2017 May 9.

PMID:
28487370
7.

Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17.

Jiang Z, Cote J, Kwon JM, Goate AM, Wu JY.

Mol Cell Biol. 2000 Jun;20(11):4036-48. Erratum in: Mol Cell Biol 2000 Jul;20(14):5360.

8.

Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.

Umeda T, Yamashita T, Kimura T, Ohnishi K, Takuma H, Ozeki T, Takashima A, Tomiyama T, Mori H.

Am J Pathol. 2013 Jul;183(1):211-25. doi: 10.1016/j.ajpath.2013.03.015. Epub 2013 May 13.

PMID:
23680655
9.

Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Zhou J, Yu Q, Zou T.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S10. doi: 10.1186/1471-2202-9-S2-S10. Review.

10.
11.
12.

Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.

Rodriguez-Martin T, Garcia-Blanco MA, Mansfield SG, Grover AC, Hutton M, Yu Q, Zhou J, Anderton BH, Gallo JM.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15659-64. Epub 2005 Oct 17.

13.

Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.

Lisowiec J, Magner D, Kierzek E, Lenartowicz E, Kierzek R.

RNA Biol. 2015;12(3):330-42. doi: 10.1080/15476286.2015.1017214.

14.
15.

Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.

Kalbfuss B, Mabon SA, Misteli T.

J Biol Chem. 2001 Nov 16;276(46):42986-93. Epub 2001 Sep 17.

16.
17.

Regulation of tau isoform expression and dementia.

D'Souza I, Schellenberg GD.

Biochim Biophys Acta. 2005 Jan 3;1739(2-3):104-15. Review.

18.

Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.

Rodriguez-Martin T, Anthony K, Garcia-Blanco MA, Mansfield SG, Anderton BH, Gallo JM.

Hum Mol Genet. 2009 Sep 1;18(17):3266-73. doi: 10.1093/hmg/ddp264. Epub 2009 Jun 4.

19.

Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.

Wren MC, Zhao J, Liu CC, Murray ME, Atagi Y, Davis MD, Fu Y, Okano HJ, Ogaki K, Strongosky AJ, Tacik P, Rademakers R, Ross OA, Dickson DW, Wszolek ZK, Kanekiyo T, Bu G.

Mol Neurodegener. 2015 Sep 15;10:46. doi: 10.1186/s13024-015-0042-7.

20.

A novel mutation at position +11 in the intron following exon 10 of the tau gene in FTDP-17.

Kowalska A, Hasegawa M, Miyamoto K, Akiguchi I, Ikemoto A, Takahashi K, Araki W, Tabira T.

J Appl Genet. 2002;43(4):535-43.

PMID:
12441638

Supplemental Content

Support Center